Capital International Investors’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-1,461,827
| Closed | -$18.4M | – | 479 |
|
2021
Q4 | $18.4M | Sell |
1,461,827
-1,514,024
| -51% | -$19.1M | ﹤0.01% | 409 |
|
2021
Q3 | $273M | Buy |
2,975,851
+239,182
| +9% | +$21.9M | 0.06% | 232 |
|
2021
Q2 | $145M | Buy |
2,736,669
+275,089
| +11% | +$14.6M | 0.03% | 271 |
|
2021
Q1 | $88.7M | Sell |
2,461,580
-118,875
| -5% | -$4.28M | 0.02% | 302 |
|
2020
Q4 | $71.7M | Buy |
2,580,455
+21,388
| +0.8% | +$594K | 0.02% | 308 |
|
2020
Q3 | $128M | Buy |
2,559,067
+776,548
| +44% | +$38.8M | 0.04% | 252 |
|
2020
Q2 | $82.5M | Buy |
1,782,519
+795,622
| +81% | +$36.8M | 0.03% | 270 |
|
2020
Q1 | $45M | Buy |
986,897
+28,972
| +3% | +$1.32M | 0.02% | 269 |
|
2019
Q4 | $53.8M | Buy |
957,925
+75,525
| +9% | +$4.24M | 0.02% | 261 |
|
2019
Q3 | $22M | Buy |
+882,400
| New | +$22M | 0.01% | 318 |
|